Results 161 to 170 of about 26,084 (258)

Epilepsy and attention deficit hyperactivity disorder:Is methylphenidate safe and effective?

, 1997
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis of epilepsy and attention deficit hyperactivity disorder (ADHD).Study design: Thirty children, aged 6.4 to 16.4 years, with epilepsy and ADHD were studied ...
Manor, O, Gross-Tsur, V., Joseph, A, Shalev, R.S, Van der Meere, J.J.   +4 more
core  

Severe self-limiting acute bilateral hearing loss following a low dose of methylphenidate for ADHD treatment: A case report. [PDF]

PCN Rep
Zandifar A, Badrfam R.
europepmc   +1 more source

Psychosis in a 47,XXX Adolescent: Clinical Management and Multidisciplinary Follow-up. [PDF]

Clin Psychopharmacol Neurosci
Bain A, Bioulac S, Amblard F, Marey I, Dondé C.   +4 more
europepmc   +1 more source

ADHD medications and drug withdrawal: A pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Takumi Ebina, Kunihiro Iwamoto, Masashi Ikeda   +2 more
wiley   +1 more source

Modelling the Neurobiology of ADHD Using Human iPSC Systems: A Multimodal Platform for Mechanistic Discovery. [PDF]

Cells
Namipashaki A, Yu H, Bellgrove MA, Hawi Z.   +3 more
europepmc   +1 more source

Subcutaneous Thrombotic Vasculopathy with Features of Leukocytoclastic Vasculitis Following Intravenous Injection of Crushed Oxycodone and Methylphenidate Tablets: A Case Report with Literature Review. [PDF]

J Clin Med
Łabędź N, Markwitz M, Głuszak P, Bowszyc-Dmochowska M, Dmochowski M, Polańska A, Dańczak-Pazdrowska A.   +6 more
europepmc   +1 more source

Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study. [PDF]

BMJ Ment Health
Ermis C, Tanskanen A, Corbeil O, Lieslehto J, Vieta E, Correll CU, Mittendorfer-Rutz E, Tiihonen J, Taipale H.   +8 more
europepmc   +1 more source

Glutamatergic Enhancement Using As-Needed Dextromethorphan and Piracetam in a Stimulant-Partially Responsive Adult With ADHD: A Single-Case Report. [PDF]

Cureus
Cheung N.
europepmc   +1 more source

Methylphenidate Treatment and Risk of Psychotic Disorder.

JAMA Psychiatry
Healy C, O'Hare K, Lång U, Metsälä J, Pulakka A, McGrath J, Migone M, Keating D, Romaniuk L, Gyllenberg D, Kajantie E, Perrett G, Hill J, Elwert F, Kelleher I.   +14 more
europepmc   +1 more source

Methylphenidate use in hyperphagic Prader-Willi syndrome: A clinical note. [PDF]

Indian J Psychiatry
Saruhan K.
europepmc   +1 more source